00000000|MMI|19.24|Diabetic Foot|C0206172|[dsyn]|["Diabetic Foot"-tx-1-"Diabetic foot"-noun-0]|TX|92/13|C14.907.320.191;C17.800.893.592.450.200;C19.246.099.500.191;C19.246.099.937.250
00000000|MMI|17.80|Cellulitis|C0007642|[patf]|["CELLULITIS"-tx-1-"Cellulitis"-noun-0]|TX|65/10|C01.539.800.130;C01.539.830.200;C17.300.185;C23.550.470.756.200
00000000|MMI|16.09|Foot Ulcer|C0085119|[acab,dsyn]|["ulcer foot"-tx-1-"ulcer foot"-noun-0]|TX|85/5,101/4|C17.800.321.250;C17.800.893.592.450
00000000|MMI|9.76|Ulcer|C0041582|[dsyn]|["ULCER"-tx-1-"ulcer"-noun-0]|TX|85/5|C23.550.891
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|143/13|
00000000|MMI|3.62|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|116/14|
00000000|MMI|3.62|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|116/14|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.45|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|110/3|
00000000|MMI|3.45|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|110/3|
00000000|MMI|3.45|Ulceration|C3887532|[patf]|["ULCER"-tx-1-"ulcer"-noun-0]|TX|85/5|
00000000|MMI|3.45|diabetic|C0241863|[fndg]|["DIABETIC"-tx-1-"Diabetic"-adj-0]|TX|92/8|
00000000|MMI|139.20|Override|C1547671|[acty]|["Override"-tx-10-"override"-verb-0,"Override"-tx-9-"Override"-verb-0,"Override"-tx-9-"overridden"-noun-0,"Override"-tx-8-"override"-verb-0,"Override"-tx-7-"Override"-verb-0,"Override"-tx-7-"override"-verb-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-4-"Override"-verb-0]|TX|2081/8;1966/8;1954/10;1779/8;[1409/8],[1426/8],[1640/8];[1596/8],[1618/8];1257/8;[906/8],[923/8],[1131/8];[724/8],[1087/8],[1109/8];[521/8],[538/8]|
00000000|MMI|119.44|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-41-"coumadin"-noun-0,"Coumadin"-tx-38-"coumadin"-noun-0,"Coumadin"-tx-36-"coumadin"-noun-0,"Coumadin"-tx-11-"coumadin"-noun-0,"Coumadin"-tx-7-"COUMADIN"-noun-0,"Coumadin"-tx-5-"COUMADIN"-noun-0]|TX|[5600/8],[5774/8];5195/8;5120/8;3240/8;1494/8;746/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|116.44|Togo|C0040363|[geoa]|["TO"-tx-41-"to"-adv-0,"TO"-tx-38-"to"-adv-0,"TO"-tx-32-"to"-adv-0,"TO"-tx-25-"to"-adv-0,"TO"-tx-10-"to"-adv-0]|TX|[5542/2],[5616/2],[5805/2];5177/2;4984/2;[4424/2],[4492/2];[2291/2],[2329/2]|Z01.058.290.190.800
00000000|MMI|116.44|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-41-"to"-adv-0,"TO"-tx-38-"to"-adv-0,"TO"-tx-32-"to"-adv-0,"TO"-tx-25-"to"-adv-0,"TO"-tx-10-"to"-adv-0]|TX|[5542/2],[5616/2],[5805/2];5177/2;4984/2;[4424/2],[4492/2];[2291/2],[2329/2]|D08.811.520.224.800
00000000|MMI|102.90|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-verb-0,"Discharge"-tx-31-"discharge"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Release"-tx-5-"RELEASE"-adj-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5926/9;5668/9;4908/9;2491/9;614/7;39/9;126/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|74.87|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-8-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-7-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-6-"SIMVASTATIN"-noun-0]|TX|1756/11;1558/11;[1219/11],[1270/11]|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|71.78|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-41-"INR"-noun-0,"INR"-tx-37-"INR"-noun-0,"INR"-tx-11-"INR's"-noun-0,"INR"-tx-10-"INR"-noun-0,"INR"-tx-10-"INR's"-noun-0]|TX|5624/3;5136/3;2356/5;2287/3;2323/5|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|69.27|Portugal|C0032729|[geoa]|["PO"-tx-25-"Po"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|4453/2;1818/2;1503/2;1288/2;[622/2],[782/2],[1001/2];[395/2],[473/2]|Z01.542.727
00000000|MMI|65.65|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-8-"WARFARIN"-noun-0,"WARFARIN"-tx-7-"WARFARIN"-noun-0,"WARFARIN"-tx-6-"WARFARIN"-noun-0,"WARFARIN"-tx-5-"WARFARIN"-noun-0]|TX|1741/8;1576/8;1237/8;1044/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|52.41|Ulcer|C0041582|[dsyn]|["ULCER"-tx-41-"ulcer"-noun-0,"ULCER"-tx-31-"ulcer"-noun-0,"ULCER"-tx-16-"ulcer"-noun-0,"ULCER"-tx-13-"ulcer"-noun-0,"ULCER"-tx-11-"ulcer"-noun-0,"Ulceration"-tx-11-"ulceration"-noun-0,"ulcerations"-tx-11-"ulcerations"-noun-0]|TX|5570/5;4973/5;3812/5;3404/5;2580/5;3115/10;3285/11|C23.550.891
00000000|MMI|48.90|Coding|C0009219|[ocac]|["code"-tx-41-"CODE"-noun-0,"code"-tx-4-"CODE"-noun-0,"code"-tx-4-"code"-noun-0]|TX|5279/4;292/4;310/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|47.68|Papillon-Lefevre Disease|C0030360|[dsyn]|["PLS"-tx-41-"Pls"-noun-0,"PLS"-tx-41-"pls"-noun-0]|TX|[5479/3],[5636/3];[5431/3],[5576/3]|C16.320.850.475.600;C17.800.428.435.600;C17.800.827.475.600
00000000|MMI|47.57|Cellulitis|C0007642|[patf]|["CELLULITIS"-tx-31-"cellulitis"-noun-0,"CELLULITIS"-tx-11-"Cellulitis"-noun-0,"CELLULITIS"-tx-11-"cellulitis"-noun-0]|TX|4958/10;[2470/10],[2560/10];2806/10|C01.539.800.130;C01.539.830.200;C17.300.185;C23.550.470.756.200
00000000|MMI|44.03|Obesity|C0028754|[dsyn]|["OBESITY"-tx-11-"obesity"-noun-0]|TX|[2763/7],[2773/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|42.52|Diabetic Foot|C0206172|[dsyn]|["diabetic foot ulcers"-tx-19-"ulcer diabetic foot"-noun-0,"Diabetic Foot"-tx-11-"Diabetic foot"-noun-0,"diabetic foot ulcer"-tx-11-"Diabetic foot ulcer"-noun-0]|TX|4134/5,4142/13;2587/13;3147/19|C14.907.320.191;C17.800.893.592.450.200;C19.246.099.500.191;C19.246.099.937.250
00000000|MMI|38.43|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-41-"PCP"-noun-0,"PCP"-tx-11-"PCP"-noun-0,"PCP"-tx-10-"PCP"-noun-0]|TX|[5332/3],[5755/3];2382/3;2273/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|38.29|Physicians|C0031831|[prog]|["Doctor"-tx-41-"doctor"-noun-0,"doctors"-tx-41-"doctors"-noun-0,"DR"-tx-27-"Dr"-noun-0,"DR"-tx-17-"Dr"-noun-0]|TX|5552/6;5471/7;4597/2;4092/2|M01.526.485.810;N02.360.810
00000000|MMI|36.83|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-41-"M.D"-noun-0,"M.D."-tx-9-"M.D"-noun-0,"M.D."-tx-8-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|5881/3;2015/3;1943/3;[1476/3],[1703/3];[587/3],[972/3],[1181/3];279/3|
00000000|MMI|35.15|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-8-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-5-"Food/Drug Interaction"-noun-0]|TX|1825/21;1326/21;837/21|G07.690.773.968.511
00000000|MMI|34.90|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-11-"DIAGNOSIS"-noun-0]|TX|[2459/9],[2607/9]|x.x.x.x.x.x.x
00000000|MMI|31.96|Consultation|C0009818|[hlca]|["Consult"-tx-26-"consult"-verb-0,"Consult"-tx-25-"consult"-verb-0,"Consults"-tx-17-"CONSULTS"-verb-0]|TX|4539/7;4404/7;3979/8|N04.452.758.849
00000000|MMI|28.67|Ambulatory Care Facilities|C0002424|[hcro,mnob]|["Clinic"-tx-41-"clinic"-noun-0,"Clinic"-tx-38-"clinic"-noun-0,"Clinic"-tx-10-"clinic"-noun-0]|TX|[5609/6],[5783/6];5204/6;2224/6|N02.278.035
00000000|MMI|28.31|Rabbi|C0684010|[prog]|["R."-tx-16-"R"-noun-0,"R."-tx-11-"R"-noun-0]|TX|3755/1;[2968/1],[3034/1]|M01.526.799.500
00000000|MMI|27.81|linezolid|C0663241|[orch,phsu]|["Linezolide"-tx-25-"linezolid"-noun-0,"Linezolide"-tx-10-"LINEZOLID"-noun-0]|TX|4456/9;2060/9|D02.065.064.463;D02.241.081.018.110.525;D03.383.129.462.600.550
00000000|MMI|27.81|Didanosine|C0012133|[nnon,phsu]|["DDI"-tx-36-"DDI"-noun-0,"DDI"-tx-11-"DDI"-noun-0]|TX|5099/3;3227/3|D03.438.759.590.616.130;D13.570.230.500.090;D13.570.583.616.130;D13.570.800.573.130
00000000|MMI|26.77|To|C1883351|[qlco]|["To"-tx-41-"to"-adv-0,"To"-tx-38-"to"-adv-0,"To"-tx-32-"to"-adv-0,"To"-tx-25-"to"-adv-0,"To"-tx-10-"to"-adv-0]|TX|[5542/2],[5616/2],[5805/2];5177/2;4984/2;[4424/2],[4492/2];[2291/2],[2329/2]|
00000000|MMI|26.27|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-38-"Pt"-noun-0,"PT"-tx-32-"Pt"-noun-0,"PT"-tx-31-"pt"-noun-0,"PT"-tx-28-"pt"-noun-0,"PT"-tx-27-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-25-"pt"-noun-0,"PT"-tx-5-"pt"-noun-0]|TX|5174/2;4981/2;4918/2;4719/2;4582/2;[4616/2],[4646/2];4481/2;734/2|
00000000|MMI|26.27|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-38-"Pt"-noun-0,"PT"-tx-32-"Pt"-noun-0,"PT"-tx-31-"pt"-noun-0,"PT"-tx-28-"pt"-noun-0,"PT"-tx-27-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-25-"pt"-noun-0,"PT"-tx-5-"pt"-noun-0]|TX|5174/2;4981/2;4918/2;4719/2;4582/2;[4616/2],[4646/2];4481/2;734/2|
00000000|MMI|25.76|Mitral Valve Prolapse Syndrome|C0026267|[dsyn]|["MITRAL VALVE PROLAPSE"-tx-11-"mitral valve prolapse"-noun-0,"Mitral prolapse"-tx-11-"mitral prolapse"-noun-0]|TX|2837/21;2819/15|C14.280.484.400.500
00000000|MMI|25.08|Edema|C0013604|[fndg]|["OEDEMA"-tx-16-"edema"-noun-0,"SWELLING"-tx-14-"swelling"-verb-0,"OEDEMA"-tx-11-"edema"-noun-0]|TX|3837/5;3482/8;2736/5|C23.888.277
00000000|MMI|24.43|Oral|C0442027|[spco]|["PO"-tx-25-"Po"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|4453/2;1818/2;1503/2;1288/2;[622/2],[782/2],[1001/2];[395/2],[473/2]|
00000000|MMI|23.59|Lesotho|C0023376|[geoa]|["LT"-tx-4-"lt"-noun-0]|TX|[450/2],[515/2]|Z01.058.290.175.400
00000000|MMI|23.44|Dominican Republic|C0013014|[geoa]|["DR"-tx-27-"Dr"-noun-0,"DR"-tx-17-"Dr"-noun-0]|TX|4597/2;4092/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|23.37|Pain|C0030193|[sosy]|["PAIN"-tx-14-"pain"-noun-0,"PAIN"-tx-11-"pain"-noun-0]|TX|3500/4;3134/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|23.29|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-5-"LISINOPRIL"-noun-0,"Lysinopril"-tx-4-"LISINOPRIL"-noun-0]|TX|677/10;479/10|D12.644.456.345.600
00000000|MMI|23.03|Order (action)|C1705178|[acty]|["Order"-tx-42-"ORDERS"-verb-0,"Ordered"-tx-23-"ordered"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5936/6;4325/7;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|23.03|Order (arrangement)|C1705176|[qlco]|["Order"-tx-42-"ORDERS"-verb-0,"Ordered"-tx-23-"ordered"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5936/6;4325/7;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|21.95|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-6-"grapefruit"-noun-0]|TX|1366/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|21.20|Urinary tract infection|C0042029|[dsyn]|["URINARY TRACT INFECTION"-tx-11-"urinary tract infection"-noun-0,"UTI"-tx-11-"uti"-noun-0]|TX|2867/23;2861/3|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|19.65|Order (document)|C1705175|[inpr]|["Order"-tx-42-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5936/6;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|19.65|Order (taxonomic)|C1705177|[clas]|["Order"-tx-42-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5936/6;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|19.65|Permutation|C1882348|[qlco]|["Order"-tx-42-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5936/6;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|19.65|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-42-"ORDERS"-verb-0,"ORDER"-tx-8-"order"-noun-0,"ORDER"-tx-7-"order"-noun-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5936/6;1864/5;1484/5;[595/5],[980/5];207/5;49/6|
00000000|MMI|19.17|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-11-"diabetes mellitus"-noun-0,"Diabetes"-tx-11-"diabetes"-noun-0]|TX|2695/17;2684/8|C18.452.394.750;C19.246
00000000|MMI|19.06|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-41-"Follow up"-adj-0,"FOLLOW-UP"-tx-41-"follow up"-adj-0,"FOLLOW-UP"-tx-38-"follow up"-adj-0,"FOLLOW-UP"-tx-10-"FOLLOW UP"-adj-0]|TX|5759/9;[5312/9],[5435/9],[5580/9],[5708/9];5180/9;2191/9|
00000000|MMI|19.06|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-41-"Follow up"-adj-0,"Follow-Up"-tx-41-"follow up"-adj-0,"Follow-Up"-tx-38-"follow up"-adj-0,"Follow-Up"-tx-10-"FOLLOW UP"-adj-0]|TX|5759/9;[5312/9],[5435/9],[5580/9],[5708/9];5180/9;2191/9|
00000000|MMI|19.06|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-41-"Follow up"-adj-0,"Follow-up"-tx-41-"follow up"-adj-0,"Follow-up"-tx-38-"follow up"-adj-0,"Follow-up"-tx-10-"FOLLOW UP"-adj-1]|TX|5759/9;[5312/9],[5435/9],[5580/9],[5708/9];5180/9;2191/9|
00000000|MMI|19.06|follow-up|C1522577|[hlca]|["Follow Up"-tx-41-"Follow up"-adj-0,"Follow Up"-tx-41-"follow up"-adj-0,"Follow Up"-tx-38-"follow up"-adj-0,"Follow Up"-tx-10-"FOLLOW UP"-adj-0]|TX|5759/9;[5312/9],[5435/9],[5580/9],[5708/9];5180/9;2191/9|
00000000|MMI|19.02|Diet|C0012155|[food]|["Diet"-tx-34-"diet"-noun-0,"Diet"-tx-10-"DIET"-noun-0]|TX|5063/4;2135/4|G07.203.650.240
00000000|MMI|18.93|Quinolones|C0034428|[orch]|["Quinolones"-tx-22-"quinolones"-noun-0,"Quinolones"-tx-11-"QUINOLONES"-noun-0]|TX|4284/10;2426/10|D03.438.810.835
00000000|MMI|18.81|Panama|C0030266|[geoa]|["PM"-tx-42-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5909/2;164/2|Z01.107.169.772
00000000|MMI|18.46|Methicillin resistant Staphylococcus aureus (organism)|C1265292|[bact]|["MRSA"-tx-25-"MRSA"-noun-0]|TX|4396/4|B03.300.390.400.800.750.100.500;B03.353.500.750.750.100.500;B03.510.100.750.750.100.500;B03.510.400.790.750.100.500
00000000|MMI|18.45|Vitamin K|C0042878|[orch,vita]|["VITAMIN K"-tx-5-"Vitamin-K"-noun-0]|TX|879/9|D02.455.426.559.847.638.721.374;D02.455.849.291.523.500;D04.615.638.721.374;x.x.x.x
00000000|MMI|17.39|Benadryl|C0700899|[orch,phsu]|["Benadryl"-tx-4-"BENADRYL"-noun-0]|TX|356/8|D02.092.471.320;D02.455.426.559.389.115.250
00000000|MMI|17.39|Cephalosporins|C3536856|[antb,orch]|["CEPHALOSPORINS"-tx-11-"Cephalosporins"-noun-0]|TX|2409/14|D02.065.589.099.249;D02.886.665.074;D04.075.080.875.099.221.249
00000000|MMI|17.39|Diphenhydramine Hydrochloride|C0004963|[orch,phsu]|["Diphenhydramine.HCl"-tx-4-"DIPHENHYDRAMINE HCL"-noun-0]|TX|367/19|D02.092.471.320;D02.455.426.559.389.115.250
00000000|MMI|17.39|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-11-"Penicillins"-noun-0]|TX|2395/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|17.39|Surgical aspects|C0038895|[ftcn]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|2926/10|x.x.x.x.x.x.x
00000000|MMI|17.39|Warfarin Sodium|C0376218|[hops,orch,phsu]|["WARFARIN SODIUM"-tx-5-"WARFARIN SODIUM"-noun-0]|TX|757/15|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|16.63|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-11-"htn"-noun-0,"HYPERTENSION"-tx-11-"hypertension"-noun-0]|TX|2715/3;2721/12|C14.907.489
00000000|MMI|16.38|Interaction|C1704675|[ftcn]|["Interaction"-tx-10-"INTERACTION"-noun-0,"Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-7-"INTERACTION"-noun-0,"Interaction"-tx-6-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0]|TX|2028/11;1728/11;1545/11;1206/11;[664/11],[1031/11]|
00000000|MMI|16.36|Staphylococcus aureus|C0038172|[bact]|["STAPH AUREUS"-tx-24-"staph aureus"-noun-0]|TX|4357/12|B03.300.390.400.800.750.100;B03.353.500.750.750.100;B03.510.100.750.750.100;B03.510.400.790.750.100
00000000|MMI|16.23|Antibiotics, Antitubercular|C0003237|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|D27.505.954.122.085.255.135
00000000|MMI|16.16|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|x.x.x.x.x.x.x
00000000|MMI|16.10|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-10-"Reason"-noun-0,"Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-7-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0]|TX|2070/6;1768/6;1585/6;1246/6;[713/6],[1076/6]|
00000000|MMI|16.04|Ulceration|C3887532|[patf]|["ULCER"-tx-41-"ulcer"-noun-0,"ULCER"-tx-31-"ulcer"-noun-0,"ULCER"-tx-16-"ulcer"-noun-0,"ULCER"-tx-13-"ulcer"-noun-0,"ULCER"-tx-11-"ulcer"-noun-0,"Ulceration"-tx-11-"ulceration"-noun-0]|TX|5570/5;4973/5;3812/5;3404/5;2580/5;3115/10|
00000000|MMI|15.98|Additional|C1524062|[ftcn]|["Added"-tx-9-"added"-verb-0,"Added"-tx-7-"added"-verb-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|1975/5;[1435/5],[1649/5];[932/5],[1140/5];547/5|
00000000|MMI|15.65|Serious|C0205404|[qlco]|["Serious"-tx-10-"SERIOUS"-adj-0,"Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-7-"SERIOUS"-adj-0,"Serious"-tx-6-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0]|TX|2020/7;1720/7;1537/7;1198/7;[656/7],[1023/7]|
00000000|MMI|15.12|Ciprofloxacin|C0008809|[orch,phsu]|["CIPROFLOXACIN"-tx-11-"CIPROFLOXACIN"-noun-0]|TX|2439/13|D03.438.810.835.322.186
00000000|MMI|15.09|Disease|C0012634|[dsyn]|["condition"-tx-41-"CONDITION"-noun-0,"condition"-tx-11-"Conditions"-noun-0]|TX|5678/9;2617/10|C23.550.288
00000000|MMI|14.67|Methods aspects|C0025664|[inpr]|["procedures"-tx-17-"PROCEDURES"-noun-0,"procedures"-tx-11-"PROCEDURES"-noun-0]|TX|3893/10;2941/10|x.x.x
00000000|MMI|14.46|Diet therapy|C0012159|[hlca]|["Diet"-tx-34-"diet"-noun-0,"Diet"-tx-10-"DIET"-noun-0]|TX|5063/4;2135/4|E02.642.249
00000000|MMI|14.43|Drawings (art)|C0013113|[inpr]|["Draw"-tx-10-"drawn"-verb-0]|TX|[2297/5],[2335/5]|V01.185.625;V02.700.300
00000000|MMI|14.33|Female|C0015780|[orga]|["FEMALE"-tx-11-"female"-noun-0]|TX|[3096/6],[3182/6]|x.x.x
00000000|MMI|14.33|Females|C0086287|[popg]|["female"-tx-11-"female"-noun-0]|TX|[3096/6],[3182/6]|x.x.x
00000000|MMI|14.15|Outpatients|C0029921|[podg]|["Out-patient"-tx-41-"out patient"-noun-0,"Out-patient"-tx-32-"out patient"-noun-0]|TX|5459/11;5002/11|M01.643.630
00000000|MMI|14.14|Erythema|C0041834|[dsyn]|["ERYTHEMA"-tx-14-"erythema"-noun-0,"Redness"-tx-11-"redness"-noun-0]|TX|3491/8;3126/7|C17.800.229
00000000|MMI|14.04|Nuchal Translucency Screen|C1449832|[diap]|["NT"-tx-16-"NT"-noun-0]|TX|3697/2|E01.370.350.850.865.500;E01.370.378.630.865.500
00000000|MMI|13.93|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|203/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|13.91|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-16-"NAD"-noun-0]|TX|3601/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|13.87|Sulfamethoxazole|C0038689|[antb,orch]|["Sulphamethoxazole"-tx-5-"SULFAMETHOXAZOLE"-noun-0]|TX|1059/16|D02.065.884.725.867;D02.092.146.807.867;D02.886.590.700.725.867
00000000|MMI|13.87|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-4-"FUROSEMIDE"-noun-0]|TX|414/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|13.86|Chronic Kidney Diseases|C1561643|[dsyn]|["CKD"-tx-40-"CKD"-noun-0]|TX|5222/3|C12.777.419.780.750;C13.351.968.419.780.750
00000000|MMI|13.45|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-41-"INR"-noun-0,"INR"-tx-37-"INR"-noun-0,"INR"-tx-11-"INR's"-noun-0,"INR"-tx-10-"INR"-noun-0,"INR"-tx-10-"INR's"-noun-0]|TX|5624/3;5136/3;2356/5;2287/3;2323/5|
00000000|MMI|13.37|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-verb-0,"Discharge"-tx-31-"discharge"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5926/9;5668/9;4908/9;2491/9;39/9|
00000000|MMI|13.37|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-41-"DISCHARGE"-verb-0,"Discharge"-tx-31-"discharge"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5926/9;5668/9;4908/9;2491/9;39/9|
00000000|MMI|12.85|Right|C0205090|[spco]|["RIGHT"-tx-27-"right"-noun-0,"R-"-tx-16-"R"-noun-0,"RIGHT"-tx-12-"right"-noun-0,"R-"-tx-11-"R"-noun-0]|TX|4678/5;3755/1;3393/5;[2968/1],[3034/1]|
00000000|MMI|12.84|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-34-"glyburide"-noun-0]|TX|5047/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|12.07|Infection|C3714514|[patf]|["Infections"-tx-11-"Infections"-noun-0,"Infections"-tx-11-"infections"-noun-0]|TX|2630/10;3301/10|C01.539
00000000|MMI|11.78|Foot Ulcer|C0085119|[acab,dsyn]|["ulcer foot"-tx-11-"ulcer foot"-noun-0]|TX|2580/5,2596/4|C17.800.321.250;C17.800.893.592.450
00000000|MMI|11.76|Sick Sinus Syndrome|C0037052|[dsyn]|["SSS"-tx-36-"SSS"-noun-0]|TX|5089/3|C14.280.067.093.249;C14.280.067.558.536;C23.550.073.093.249;C23.550.073.425.440
00000000|MMI|11.68|Antibiotics|C0003232|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|D27.505.954.122.085
00000000|MMI|11.68|Ivory Coast|C0022326|[geoa]|["IV"-tx-15-"IV"-noun-0]|TX|3529/2|Z01.058.290.190.272
00000000|MMI|11.63|Physician-Patient Relations|C0031830|[socb]|["patient Doctors"-tx-41-"patient doctors"-noun-0]|TX|5463/15|F01.829.401.650.675;N05.300.660.625
00000000|MMI|11.61|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-5-"POTASSIUM CHLORIDE"-noun-0]|TX|694/18|D01.210.450.150.750;D01.745.625
00000000|MMI|11.61|Fluorides|C0016327|[inch,phsu]|["F-"-tx-10-"f"-noun-0]|TX|2319/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|11.59|Lanthanum|C0023031|[elii]|["La"-tx-1-"La"-noun-0]|TX|95/2|D01.268.558.362.500;D01.552.550.399.500;x.x.x.x
00000000|MMI|11.58|Lebanon|C0023190|[geoa]|["LE"-tx-11-"LE"-noun-0]|TX|3282/2|Z01.252.245.500.450
00000000|MMI|10.93|Unasyn|C0147814|[antb,orch]|["Unasyn"-tx-30-"unasyn"-noun-0,"Unasyn"-tx-28-"unasyn"-noun-0,"Unasyn"-tx-25-"unasyn"-noun-0,"Unasyn"-tx-21-"unasyn"-noun-0]|TX|4876/6;4774/6;4432/6;4242/6|
00000000|MMI|10.76|Hospital admission|C0184666|[hlca]|["admitted"-tx-17-"admitted"-verb-0,"admitted"-tx-15-"Admitted"-verb-0,"Admission"-tx-11-"Admission"-noun-0,"Admit"-tx-11-"ADMIT"-verb-0]|TX|3862/8;3516/8;2548/9;2453/5|
00000000|MMI|10.57|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-40-"baseline"-noun-0]|TX|5256/8|x.x.x.x
00000000|MMI|10.57|Dermatitis, Atopic|C0011615|[dsyn]|["ATOPIC DERMATITIS"-tx-11-"atopic dermatitis"-noun-0]|TX|2893/17|C16.320.850.210;C17.800.174.193;C17.800.815.193;C17.800.827.210;C20.543.480.343
00000000|MMI|10.57|Desiccation|C0011682|[npop]|["Dry"-tx-41-"dry"-verb-0]|TX|5808/3|E05.196.335;G02.149.767.530;G02.842.750.530
00000000|MMI|10.57|Disease susceptibility|C0012655|[clna]|["susceptibilities"-tx-25-"Susceptibilities"-noun-0]|TX|4372/16|C23.550.291.687;G07.100.250
00000000|MMI|10.57|Dyspnea|C0013404|[sosy]|["breathing difficulty"-tx-29-"breathing difficulty"-noun-1]|TX|4794/20|C08.618.326;C23.888.852.371
00000000|MMI|10.57|Eczema|C0013595|[dsyn]|["Atopic Dermatitis"-tx-11-"atopic dermatitis"-noun-0]|TX|2893/17|C17.800.174.620;C17.800.815.620
00000000|MMI|10.57|Ensure (product)|C0218063|[food]|["ENSURE"-tx-41-"ensure"-verb-0]|TX|5354/6|x.x.x.x
00000000|MMI|10.57|Orthopedics|C0029355|[bmod]|["Orthopedic Surgery"-tx-10-"orthopedic surgery"-noun-0]|TX|2252/18|H02.403.810.494
00000000|MMI|10.57|urinastatin|C0077906|[aapp,phsu]|["UTI"-tx-11-"uti"-noun-0]|TX|2861/3|x.x.x.x
00000000|MMI|10.47|Daily|C0332173|[tmco]|["Daily"-tx-41-"daily"-adj-0,"Daily"-tx-41-"daily"-adv-0,"QD"-tx-4-"QD"-noun-0]|TX|[5425/5],[5795/5];[5425/5],[5795/5];[434/2],[476/2]|
00000000|MMI|10.18|Clinic|C0442592|[hcro,mnob]|["Clinic"-tx-41-"clinic"-noun-0,"Clinic"-tx-38-"clinic"-noun-0,"Clinic"-tx-10-"clinic"-noun-0]|TX|[5609/6],[5783/6];5204/6;2224/6|
00000000|MMI|9.78|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-8-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|1847/11;1348/11|I02.903
00000000|MMI|9.77|Woman|C0043210|[popg]|["female"-tx-11-"female"-noun-0]|TX|[3096/6],[3182/6]|M01.975
00000000|MMI|9.63|Blood Vessel|C0005847|[bpoc]|["Vascular"-tx-41-"vascular"-adj-0,"Vascular"-tx-27-"vascular"-adj-0]|TX|5730/8;4695/8|A07.231
00000000|MMI|9.48|Chest|C0817096|[blor]|["CHEST"-tx-16-"CHEST"-noun-0]|TX|3618/5|A01.923.761;A02.835.232.904
00000000|MMI|9.48|Solomon Islands|C0037623|[geoa]|["BP"-tx-16-"BP"-noun-0]|TX|3567/2|Z01.639.760.590
00000000|MMI|9.44|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-41-"PLAN"-noun-0]|TX|5702/4|C10.228.140.744
00000000|MMI|9.38|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|203/3|E04.157.310;E04.950.300.299
00000000|MMI|9.32|Mongolia|C0026410|[geoa]|["MG"-tx-5-"MG"-noun-0]|TX|779/2|Z01.252.474.651
00000000|MMI|9.32|Pruritus|C0033774|[sosy]|["ITCHING"-tx-4-"Itching"-noun-0]|TX|406/7|C17.800.685;C23.888.885.625
00000000|MMI|9.30|9-(1'-hydroxy-2'-(hydroxymethyl)ethoxy)methylguanine|C0651569|[nnon]|["9-MG"-tx-6-"MG 9"-noun-0]|TX|1285/2,1307/1|x.x.x.x
00000000|MMI|9.30|Christmas Island|C0006888|[geoa]|["CXR"-tx-11-"cxr"-noun-0]|TX|3049/3|Z01.639.100;Z01.678.100.373
00000000|MMI|8.29|Complication Aspects|C1171258|[patf]|["complications"-tx-11-"Complications"-noun-0]|TX|2643/13|x.x.x
00000000|MMI|8.29|Dermatitis|C0011603|[dsyn]|["DERMATITIS"-tx-11-"dermatitis"-noun-0]|TX|2913/10|C17.800.174
00000000|MMI|8.29|Peripheral Vascular Diseases|C0085096|[dsyn]|["pvd"-tx-11-"PVD"-noun-0]|TX|3201/3|C14.907.617
00000000|MMI|8.29|Vascular Surgical Procedures|C0042381|[topp]|["Vascular surgery"-tx-10-"vascular surgery"-noun-0]|TX|2233/16|E04.100.814
00000000|MMI|8.22|4+ Answer to question|C3838679|[fndg]|["4+"-tx-39-"4"-integer-0,"4+"-tx-12-"4"-fraction-0,"4+"-tx-6-"4"-fraction-0]|TX|5217/1;3346/1;1319/1|
00000000|MMI|8.21|Followed by|C0332283|[tmco]|["Followed by"-tx-17-"followed by"-verb-0,"Followed by"-tx-11-"followed by"-verb-0,"follow"-tx-8-"follow"-verb-0]|TX|4080/11;2370/11;1794/6|
00000000|MMI|8.17|Identifier|C0600091|[inpr]|["ID"-tx-25-"ID"-noun-0,"ID"-tx-17-"ID"-noun-0,"ID"-tx-11-"ID"-noun-0]|TX|4401/2;3995/2;3086/2|
00000000|MMI|8.17|Immune diffusion|C1441613|[lbpr]|["ID"-tx-25-"ID"-noun-0,"ID"-tx-17-"ID"-noun-0,"ID"-tx-11-"ID"-noun-0]|TX|4401/2;3995/2;3086/2|
00000000|MMI|8.03|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-14-"Now"-adv-0,"Now"-tx-11-"now"-adv-0,"Now"-tx-5-"NOW"-adv-0]|TX|3471/3;3218/3;798/3|
00000000|MMI|8.03|ALYREF gene|C1425988|[gngm]|["REF"-tx-7-"ref"-noun-0,"REF"-tx-5-"ref"-noun-0]|TX|1508/3;[627/3],[1006/3]|
00000000|MMI|8.01|Doctor - Title|C2348314|[cnce]|["Doctor"-tx-41-"doctor"-noun-0,"Dr."-tx-27-"Dr"-noun-0,"Dr."-tx-17-"Dr"-noun-0]|TX|5552/6;4597/2;4092/2|
00000000|MMI|7.93|Checking (action)|C1283174|[acty]|["Check"-tx-41-"check"-verb-0,"Checked"-tx-41-"checked"-adj-0,"Check"-tx-37-"check"-noun-0]|TX|5559/5;5628/7;5140/5|
00000000|MMI|7.87|Admission activity|C0809949|[hlca]|["Admitted"-tx-17-"admitted"-verb-0,"Admitted"-tx-15-"Admitted"-verb-0,"Admission"-tx-11-"Admission"-noun-0]|TX|3862/8;3516/8;2548/9|
00000000|MMI|7.77|30%|C3842588|[fndg]|["30%"-tx-7-"30"-fraction-0,"30%"-tx-5-"30"-fraction-0,"30%"-tx-4-"30"-fraction-0]|TX|1446/2;1151/2;558/2|
00000000|MMI|7.66|R prime|C2603358|[clna]|["R'"-tx-16-"R"-noun-0,"R'"-tx-11-"R"-noun-0]|TX|3755/1;[2968/1],[3034/1]|
00000000|MMI|7.64|23|C0450348|[qnco]|["23"-tx-17-"23"-fraction-0]|TX|[3859/2],[3907/2],[3953/2]|
00000000|MMI|7.60|Code|C0805701|[inpr]|["CODE"-tx-41-"CODE"-noun-0,"CODE"-tx-4-"CODE"-noun-0,"CODE"-tx-4-"code"-noun-0]|TX|5279/4;292/4;310/4|
00000000|MMI|7.60|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-41-"CODE"-noun-0,"Code"-tx-4-"CODE"-noun-0,"Code"-tx-4-"code"-noun-0]|TX|5279/4;292/4;310/4|
00000000|MMI|7.54|Out (direction)|C0439787|[spco]|["Out"-tx-41-"out"-noun-0,"Out"-tx-27-"out"-adv-0]|TX|5459/3;[4612/3],[4642/3]|
00000000|MMI|7.54|Removed|C0849355|[qlco]|["Out"-tx-41-"out"-noun-0,"Out"-tx-27-"out"-adv-0]|TX|5459/3;[4612/3],[4642/3]|
00000000|MMI|7.50|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-7-"Previous"-adj-0,"previous"-tx-5-"Previous"-adj-0]|TX|1609/8;1100/8|
00000000|MMI|7.50|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|[2459/9],[2607/9]|E01
00000000|MMI|7.50|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|[2459/9],[2607/9]|
00000000|MMI|7.50|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-16-"edema"-noun-0,"Edema"-tx-11-"edema"-noun-0]|TX|3837/5;2736/5|
00000000|MMI|7.50|Entire left foot|C1279999|[bpoc]|["Left foot"-tx-16-"Left foot"-noun-0,"Left foot"-tx-12-"left foot"-noun-0]|TX|3733/9;3326/9|
00000000|MMI|7.50|Hold (action)|C1948035|[acty]|["Hold"-tx-4-"HOLD"-verb-0]|TX|[437/4],[502/4]|
00000000|MMI|7.50|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-4-"HOLD"-verb-0]|TX|[437/4],[502/4]|
00000000|MMI|7.50|Information|C1533716|[idcn]|["INFORMATION"-tx-7-"information"-noun-0,"INFORMATION"-tx-5-"information"-noun-0]|TX|1627/11;1118/11|
00000000|MMI|7.50|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-11-"obesity"-noun-0]|TX|[2763/7],[2773/7]|
00000000|MMI|7.50|Previous|C0205156|[tmco]|["Previous"-tx-7-"Previous"-adj-0,"Previous"-tx-5-"Previous"-adj-0]|TX|1609/8;1100/8|
00000000|MMI|7.50|Structure of left foot|C0230461|[bpoc]|["Left Foot"-tx-16-"Left foot"-noun-0,"Left Foot"-tx-12-"left foot"-noun-0]|TX|3733/9;3326/9|
00000000|MMI|7.50|Take|C1515187|[hlca]|["Take"-tx-41-"take"-verb-0,"Take"-tx-25-"take"-verb-0]|TX|5640/4;4495/4|
00000000|MMI|7.50|amputated|C0231447|[fndg]|["Amputated"-tx-16-"amputated"-verb-0,"Amputated"-tx-12-"amputated"-verb-0]|TX|3743/9;3336/9|
00000000|MMI|7.50|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-4-"HOLD"-verb-0]|TX|[437/4],[502/4]|
00000000|MMI|7.50|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-42-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5936/6;49/6|
00000000|MMI|7.21|Urgent Care Centers|C1710587|[hcro,mnob]|["Urgent Care Clinic"-tx-41-"urgent care clinic"-noun-0]|TX|5488/18|N02.278.035
00000000|MMI|7.21|Abdomen|C0000726|[blor]|["abd"-tx-16-"ABD"-noun-0]|TX|3685/3|A01.923.047
00000000|MMI|7.15|Food|C0016452|[food]|["FOODS"-tx-5-"foods"-noun-0]|TX|900/5|G07.203.300;J02.500
00000000|MMI|7.15|Appointments|C0003629|[idcn]|["Appointment"-tx-10-"APPOINTMENT"-noun-0]|TX|2201/11|N04.452.095
00000000|MMI|7.13|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|H02.403.044
00000000|MMI|7.12|Amputation|C0002688|[topp]|["AMPUTATION"-tx-12-"amputation"-noun-0]|TX|3375/10|E04.555.080
00000000|MMI|7.12|Historical aspects qualifier|C0019665|[ftcn]|["history"-tx-11-"history"-noun-0]|TX|3261/7|x.x.x
00000000|MMI|7.04|Communicable Diseases|C0009450|[dsyn]|["Infectious Disease"-tx-8-"infectious disease"-noun-0]|TX|1883/18|C01.539.221
00000000|MMI|7.04|Neurogenic arthropathy|C0003892|[dsyn]|["CHARCOT JOINT"-tx-16-"charcot joint"-noun-0]|TX|3762/13|C05.550.186
00000000|MMI|7.03|Education, Pharmacy|C0013642|[edac]|["Pharmacy Instruction"-tx-5-"Pharmacy Instruction"-noun-0]|TX|819/8,859/11|I02.358.525
00000000|MMI|6.02|Orthopedic Surgical Procedures|C1136201|[topp]|["Orthopedic surgery"-tx-10-"orthopedic surgery"-noun-0]|TX|2252/18|E02.718;E04.555
00000000|MMI|5.96|Condition|C0348080|[qlco]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5678/9;2617/10|
00000000|MMI|5.96|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5678/9;2617/10|
00000000|MMI|5.96|Logical Condition|C1705253|[cnce]|["Condition"-tx-41-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5678/9;2617/10|
00000000|MMI|5.76|Show|C1547282|[anim]|["Show"-tx-31-"shown"-verb-0,"Show"-tx-25-"showed"-verb-0]|TX|4925/5;4389/6|
00000000|MMI|5.54|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-17-"PROCEDURES"-noun-0,"PROCEDURES"-tx-11-"PROCEDURES"-noun-0]|TX|3893/10;2941/10|
00000000|MMI|5.54|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-17-"PROCEDURES"-noun-0,"Procedures"-tx-11-"PROCEDURES"-noun-0]|TX|3893/10;2941/10|
00000000|MMI|5.54|Status|C0449438|[qlco]|["Status"-tx-16-"STATUS"-noun-0,"Status"-tx-4-"STATUS"-noun-0]|TX|3542/6;297/6|
00000000|MMI|5.45|Ortho-|C0812371|[idcn]|["Ortho"-tx-26-"Ortho"-adj-0,"Ortho"-tx-17-"Ortho"-adj-0]|TX|4533/5;4072/5|
00000000|MMI|5.40|Dressing change|C0085671|[topp]|["wound dressing change"-tx-41-"wound dressing changes"-noun-0,"Dressing change"-tx-13-"dressing changes"-noun-0]|TX|5393/22;3437/16|
00000000|MMI|5.40|Diabetic foot ulcer|C1456868|[dsyn]|["Diabetic foot ulcers"-tx-19-"ulcer diabetic foot"-noun-0,"Diabetic foot ulcer"-tx-11-"Diabetic foot ulcer"-noun-0]|TX|4134/5,4142/13;3147/19|
00000000|MMI|5.34|Discontinued|C1444662|[fndg]|["Discontinued"-tx-30-"discontinued"-verb-0,"D/C"-tx-1-"D/C"-noun-1]|TX|4887/12;203/3|
00000000|MMI|5.33|Basal Diet|C2983588|[food]|["DIET"-tx-34-"diet"-noun-0,"DIET"-tx-10-"DIET"-noun-0]|TX|5063/4;2135/4|
00000000|MMI|5.33|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-34-"diet"-noun-0,"Diet"-tx-10-"DIET"-noun-0]|TX|5063/4;2135/4|
00000000|MMI|5.33|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-4-"lt"-noun-0]|TX|[450/2],[515/2]|
00000000|MMI|5.33|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-34-"diet"-noun-0,"DIET"-tx-10-"DIET"-noun-0]|TX|5063/4;2135/4|
00000000|MMI|5.33|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-4-"lt"-noun-0]|TX|[450/2],[515/2]|
00000000|MMI|5.32|Treated with|C0332293|[topp]|["Treated with"-tx-30-"treated with"-verb-0,"Treated with"-tx-13-"treated with"-verb-0]|TX|4847/12;3424/12|
00000000|MMI|5.30|Dermal - anatomy qualifier|C0221928|[qlco]|["derm"-tx-41-"derm"-noun-0,"derm"-tx-10-"derm"-noun-0]|TX|5746/4;2219/4|
00000000|MMI|5.27|Beginning|C0439659|[tmco]|["Start"-tx-6-"Starting"-noun-0,"Start"-tx-5-"Starting"-verb-0]|TX|1295/8;789/8|
00000000|MMI|5.26|+2|C0740116|[qnco]|["+2"-tx-33-"2"-integer-0,"+2"-tx-24-"2"-integer-0]|TX|5032/1;4354/1|
00000000|MMI|5.26|2+|C3833492|[fndg]|["2+"-tx-33-"2"-integer-0,"2+"-tx-24-"2"-integer-0]|TX|5032/1;4354/1|
00000000|MMI|5.26|2+ Score|C2827735|[qnco]|["2+"-tx-33-"2"-integer-0,"2+"-tx-24-"2"-integer-0]|TX|5032/1;4354/1|
00000000|MMI|5.26|2+ Score, WHO|C2981700|[clas]|["2+"-tx-33-"2"-integer-0,"2+"-tx-24-"2"-integer-0]|TX|5032/1;4354/1|
00000000|MMI|5.24|High|C0205250|[qlco]|["Elevated"-tx-41-"elevated"-verb-0,"High"-tx-5-"high"-adj-0]|TX|5380/8;874/4|
00000000|MMI|5.23|Quinolone Antibacterial Agents|C1533693|[orch,phsu]|["QUINOLONES"-tx-22-"quinolones"-noun-0,"QUINOLONES"-tx-11-"QUINOLONES"-noun-0]|TX|4284/10;2426/10|
00000000|MMI|5.23|90%|C3842582|[fndg]|["90%"-tx-4-"90"-integer-0]|TX|[453/2],[518/2]|
00000000|MMI|5.23|<90|C0439087|[qnco]|["<90"-tx-4-"90"-integer-0]|TX|[453/2],[518/2]|
00000000|MMI|5.23|>90|C0439083|[qnco]|[">90"-tx-4-"90"-integer-0]|TX|[453/2],[518/2]|
00000000|MMI|5.22|Summary (document)|C1706244|[inpr]|["Summary"-tx-41-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5840/7;232/7|
00000000|MMI|5.22|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-41-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5840/7;232/7|
00000000|MMI|5.21|Radioisotope scan of bone|C0203668|[diap]|["Bone Scan"-tx-23-"Bone scan"-noun-0,"Bone Scan"-tx-11-"bone scan"-noun-0]|TX|4315/9;3039/9|
00000000|MMI|5.21|Views^W radionuclide Intravenous:Finding:Point in time:Bone:Narrative:Radnuc|C0882187|[clna]|["Bone Scan"-tx-23-"Bone scan"-noun-0,"Bone Scan"-tx-11-"bone scan"-noun-0]|TX|4315/9;3039/9|
00000000|MMI|5.21|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-8-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|1847/11;1348/11|
00000000|MMI|5.21|Instructions|C1442085|[idcn]|["instruction"-tx-8-"Instruction"-noun-0,"instruction"-tx-6-"Instruction"-noun-0]|TX|1847/11;1348/11|
00000000|MMI|5.20|Female Phenotype|C1705498|[qlco]|["Female"-tx-11-"female"-noun-0]|TX|[3096/6],[3182/6]|
00000000|MMI|5.20|Female, Self-Report|C1705497|[qlco]|["Female"-tx-11-"female"-noun-0]|TX|[3096/6],[3182/6]|
00000000|MMI|5.20|Subject Continuance|C2826258|[evnt]|["CONT"-tx-41-"Cont"-noun-0,"CONT"-tx-25-"cont"-verb-0]|TX|5790/4;4427/4|
00000000|MMI|5.18|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-27-"Dr"-noun-0,"DR"-tx-17-"Dr"-noun-0]|TX|4597/2;4092/2|
00000000|MMI|5.18|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-27-"Dr"-noun-0,"DR"-tx-17-"Dr"-noun-0]|TX|4597/2;4092/2|
00000000|MMI|5.15|Drainage procedure|C0013103|[topp]|["drain"-tx-16-"draining"-verb-0]|TX|3803/8|E02.309;E04.237
00000000|MMI|5.14|Plain x-ray|C1306645|[diap]|["Plain film"-tx-20-"Plain films"-noun-0,"Plain film"-tx-17-"plain films"-noun-0]|TX|4178/11;3916/11|
00000000|MMI|5.11|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-42-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5909/2;164/2|
00000000|MMI|5.10|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-14-"pain"-noun-0,"Pain NOS"-tx-11-"pain"-noun-0]|TX|3500/4;3134/4|
00000000|MMI|5.07|Adverse Event Associated with Vascular|C1558950|[fndg]|["VASCULAR"-tx-41-"vascular"-adj-0,"VASCULAR"-tx-27-"vascular"-adj-0]|TX|5730/8;4695/8|
00000000|MMI|5.07|Vascular|C1801960|[qlco]|["Vascular"-tx-41-"vascular"-adj-0,"Vascular"-tx-27-"vascular"-adj-0]|TX|5730/8;4695/8|
00000000|MMI|5.06|10%|C3842590|[fndg]|["10%"-tx-7-"10"-fraction-0,"10%"-tx-4-"10"-integer-0]|TX|1658/2;490/2|
00000000|MMI|5.06|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-11-"RESUME"-noun-0,"Resume"-tx-10-"Resume"-noun-0]|TX|3059/6;2167/6|
00000000|MMI|5.06|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-11-"RESUME"-noun-0,"Resume"-tx-10-"Resume"-noun-0]|TX|3059/6;2167/6|
00000000|MMI|5.06|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-11-"RESUME"-noun-0,"resume"-tx-10-"Resume"-noun-0]|TX|3059/6;2167/6|
00000000|MMI|5.04|Approval (document)|C2346845|[inpr]|["Approval"-tx-8-"approval"-noun-0,"Approval"-tx-5-"Approval"-noun-0]|TX|1902/8;828/8|
00000000|MMI|5.04|Approved|C0205540|[qlco]|["Approval"-tx-8-"approval"-noun-0,"Approval"-tx-5-"Approval"-noun-0]|TX|1902/8;828/8|
00000000|MMI|5.04|Letter of Authorization|C2697909|[rnlw]|["Approval"-tx-8-"approval"-noun-0,"Approval"-tx-5-"Approval"-noun-0]|TX|1902/8;828/8|
00000000|MMI|5.02|Full|C0443225|[qlco]|["Full"-tx-41-"FULL"-adj-0,"Full"-tx-4-"Full"-adj-0]|TX|5274/4;305/4|
00000000|MMI|5.00|60%|C3842585|[fndg]|["60%"-tx-11-"60"-integer-0]|TX|[3090/2],[3176/2]|
00000000|MMI|5.00|CDR2 gene|C1413296|[gngm]|["Yo"-tx-11-"YO"-noun-0]|TX|[3093/2],[3179/2]|
00000000|MMI|4.96|Right sided|C0444532|[spco]|["Right"-tx-27-"right"-noun-0,"Right"-tx-12-"right"-noun-0]|TX|4678/5;3393/5|
00000000|MMI|4.93|Neck|C0027530|[blor]|["NECK"-tx-16-"NECK"-noun-0]|TX|3605/4|A01.598
00000000|MMI|4.87|Medicine|C0025118|[bmod]|["Medicine"-tx-17-"medicine"-noun-0]|TX|3874/8|H02.403
00000000|MMI|4.85|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|C20.543
00000000|MMI|4.85|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|C20.543
00000000|MMI|4.84|History|C0019664|[ocdi]|["History"-tx-11-"history"-noun-0]|TX|3261/7|K01.400
00000000|MMI|4.75|Alkalies|C0002055|[inch]|["base"-tx-16-"base"-noun-0]|TX|3668/4|D01.045
00000000|MMI|3.74|+5|C0728893|[qnco]|["+5"-tx-40-"5"-integer-0]|TX|5269/1|
00000000|MMI|3.74|1 - 9%|C3842508|[fndg]|["1 - 9%"-tx-13-"1/9"-fraction-0]|TX|3420/3|
00000000|MMI|3.74|1+|C3816745|[fndg]|["1+"-tx-18-"1"-integer-0]|TX|4125/1|
00000000|MMI|3.74|1+ Score|C2827734|[qnco]|["1+"-tx-18-"1"-integer-0]|TX|4125/1|
00000000|MMI|3.74|1+ Score, WHO|C2981698|[clas]|["1+"-tx-18-"1"-integer-0]|TX|4125/1|
00000000|MMI|3.74|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-35-"3"-integer-0]|TX|5081/1|
00000000|MMI|3.74|3+ Score|C2827736|[qnco]|["3+"-tx-35-"3"-integer-0]|TX|5081/1|
00000000|MMI|3.74|3+ Score, WHO|C2981702|[clas]|["3+"-tx-35-"3"-integer-0]|TX|5081/1|
00000000|MMI|3.74|7 days|C1547085|[tmco]|["7 days"-tx-10-"7 days"-noun-0]|TX|2347/6|
00000000|MMI|3.74|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-35-"3"-integer-0]|TX|5081/1|
00000000|MMI|3.74|>5|C0439084|[qnco]|[">5"-tx-40-"5"-integer-0]|TX|5269/1|
00000000|MMI|3.74|AMBP gene|C1412376|[gngm]|["UTI"-tx-11-"uti"-noun-0]|TX|2861/3|
00000000|MMI|3.74|Absent|C0332197|[ftcn]|["Absent"-tx-20-"absent"-adj-0]|TX|4222/6|
00000000|MMI|3.74|Absent Adverse Event|C2699517|[fndg]|["ABSENT"-tx-20-"absent"-adj-0]|TX|4222/6|
00000000|MMI|3.74|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|2926/10|
00000000|MMI|3.74|Affecting|C0392760|[ftcn]|["Affecting"-tx-11-"affecting"-verb-0]|TX|2659/9|
00000000|MMI|3.74|Approximate|C0332232|[qlco]|["Approximate"-tx-10-"approximate"-adj-0]|TX|2118/11|
00000000|MMI|3.74|Arikaree language|C1555622|[lang]|["Ris"-tx-34-"RISS"-noun-0]|TX|5070/4|
00000000|MMI|3.74|Baseline|C1442488|[qnco]|["Baseline"-tx-40-"baseline"-noun-0]|TX|5256/8|
00000000|MMI|3.74|C-Circle|C3538933|[celc]|["CC"-tx-11-"CC"-noun-0]|TX|3107/2|
00000000|MMI|3.74|CDISC Events Class|C3541888|[clas]|["EVENTS"-tx-17-"EVENTS"-noun-0]|TX|3849/6|
00000000|MMI|3.74|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-41-"call"-verb-0]|TX|5483/4|
00000000|MMI|3.74|Complication|C0009566|[patf]|["Complications"-tx-11-"Complications"-noun-0]|TX|2643/13|
00000000|MMI|3.74|Decision|C0679006|[menp]|["Call"-tx-41-"call"-verb-0]|TX|5483/4|
00000000|MMI|3.74|Device Exposure Domain|C3538936|[idcn]|["DX"-tx-11-"DX"-noun-0]|TX|3143/2|
00000000|MMI|3.74|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|3.74|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|3.74|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-3-"PH.D"-noun-0]|TX|286/4|
00000000|MMI|3.74|Dry|C0205222|[qlco]|["Dry"-tx-41-"dry"-verb-0]|TX|5808/3|
00000000|MMI|3.74|Dryness (characteristic)|C1512080|[qlco]|["Dry"-tx-41-"dry"-verb-0]|TX|5808/3|
00000000|MMI|3.74|Elevated|C3163633|[qlco]|["Elevated"-tx-41-"elevated"-verb-0]|TX|5380/8|
00000000|MMI|3.74|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-21-"ED"-noun-0]|TX|4252/2|
00000000|MMI|3.74|Entire right foot|C1279998|[bpoc]|["Right foot"-tx-41-"right foot"-noun-0]|TX|5366/10|
00000000|MMI|3.74|Event|C0441471|[evnt]|["Events"-tx-17-"EVENTS"-noun-0]|TX|3849/6|
00000000|MMI|3.74|Follow|C1719822|[inpr]|["Follow"-tx-8-"follow"-verb-0]|TX|1794/6|
00000000|MMI|3.74|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1366/10|
00000000|MMI|3.74|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1366/10|
00000000|MMI|3.74|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1366/10|
00000000|MMI|3.74|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|2926/10|
00000000|MMI|3.74|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-11-"hypertension"-noun-0]|TX|2721/12|
00000000|MMI|3.74|Involvement with|C1314939|[ftcn]|["Affecting"-tx-11-"affecting"-verb-0]|TX|2659/9|
00000000|MMI|3.74|Marked|C1706089|[qlco]|["MARKED"-tx-31-"marked"-verb-0]|TX|4931/6|
00000000|MMI|3.74|Massive|C0522501|[qlco]|["Marked"-tx-31-"marked"-verb-0]|TX|4931/6|
00000000|MMI|3.74|Moist|C0205381|[qlco]|["Wet"-tx-41-"wet"-verb-0]|TX|5801/3|
00000000|MMI|3.74|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|183/14|
00000000|MMI|3.74|Orthopaedic Surgery (physician group)|C1555794|[prog]|["Orthopaedic Surgery"-tx-10-"orthopedic surgery"-noun-0]|TX|2252/18|
00000000|MMI|3.74|Orthopedic Surgery (discipline)|C0162439|[bmod]|["Surgery, Orthopedic"-tx-10-"orthopedic surgery"-noun-0]|TX|2252/18|
00000000|MMI|3.74|PROBLEM LIST|C0552582|[inpr]|["PROBLEM LIST"-tx-18-"PROBLEM LIST"-noun-0]|TX|4108/12|
00000000|MMI|3.74|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|183/14|
00000000|MMI|3.74|Peripheral edema|C0085649|[fndg]|["Peripheral oedema"-tx-11-"peripheral edema"-noun-0]|TX|2744/16|
00000000|MMI|3.74|RASL12 gene|C1428956|[gngm]|["RIS"-tx-34-"RISS"-noun-0]|TX|5070/4|
00000000|MMI|3.74|Recommendation|C0034866|[idcn]|["Recommended"-tx-25-"recommended"-verb-0]|TX|4412/11|
00000000|MMI|3.74|Recurrent cellulitis|C0742020|[dsyn]|["Cellulitis, recurrent"-tx-11-"recurrent cellulitis"-noun-0]|TX|2783/20|
00000000|MMI|3.74|Recurrent urinary tract infection|C0262655|[dsyn]|["Urinary tract infection"-tx-11-"urinary tract infection"-noun-0]|TX|2867/23|
00000000|MMI|3.74|Refused|C1705116|[acty]|["Refused"-tx-25-"refused"-verb-0]|TX|4484/7|
00000000|MMI|3.74|Refused - Completion Status for valid values|C1548564|[idcn]|["Refused"-tx-25-"refused"-verb-0]|TX|4484/7|
00000000|MMI|3.74|Requirement|C1514873|[ftcn]|["Required"-tx-10-"Required"-verb-0]|TX|2107/8|
00000000|MMI|3.74|S prime|C2603362|[clna]|["S'"-tx-10-"("-noun-0]|TX|2212/1|
00000000|MMI|3.74|Structure of right foot|C0230460|[bpoc]|["Right Foot"-tx-41-"right foot"-noun-0]|TX|5366/10|
00000000|MMI|3.74|Susceptibility (property) (qualifier value)|C1264642|[ftcn]|["susceptibilities"-tx-25-"Susceptibilities"-noun-0]|TX|4372/16|
00000000|MMI|3.74|Swelling|C0038999|[fndg]|["SWELLING"-tx-14-"swelling"-verb-0]|TX|3482/8|
00000000|MMI|3.74|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-29-"symptoms"-noun-1]|TX|4828/8|
00000000|MMI|3.74|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-29-"symptoms"-noun-0]|TX|4828/8|
00000000|MMI|3.74|Vascular surgery specialty|C3714645|[bmod]|["Vascular Surgery"-tx-10-"vascular surgery"-noun-0]|TX|2233/16|
00000000|MMI|3.74|Wound Dressings (device)|C0460765|[medd]|["wound dressings"-tx-41-"wound dressings"-noun-0]|TX|5812/15|
00000000|MMI|3.74|multiple allergies|C0740281|[dsyn]|["multiple allergies"-tx-17-"multiple allergies"-noun-0]|TX|4004/18|
00000000|MMI|3.74|per second|C0565930|[qnco]|["/s"-tx-10-"("-noun-0]|TX|2212/1|
00000000|MMI|3.74|problem list - observation|C1553895|[inpr]|["problem list"-tx-18-"PROBLEM LIST"-noun-0]|TX|4108/12|
00000000|MMI|3.74|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-11-"TREATMENTS/PROCEDURES"-noun-0]|TX|3001/21|
00000000|MMI|2.87|Concept Attribute|C0449234|[idcn]|["Attribute"-tx-28-"attributed"-verb-0]|TX|4753/10|
00000000|MMI|2.87|Drain device|C0180499|[medd]|["DRAIN"-tx-16-"draining"-verb-0]|TX|3803/8|
00000000|MMI|2.87|Object Attribute|C1882133|[qlco]|["Attribute"-tx-28-"attributed"-verb-0]|TX|4753/10|
00000000|MMI|2.87|Protection Element Attribute|C1704772|[cnce]|["Attribute"-tx-28-"attributed"-verb-0]|TX|4753/10|
00000000|MMI|2.71|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-4-"DISCHARGE MEDICATIONS"-noun-0]|TX|333/21|
00000000|MMI|2.69|Debridement of foot ulcer|C0730080|[topp]|["Debridement of foot ulcer"-tx-11-"debridement of foot ulcer"-noun-0]|TX|2953/14,2970/10|
00000000|MMI|2.67|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-11-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2481/9,2501/9|
00000000|MMI|2.67|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-11-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2481/9,2501/9|
00000000|MMI|2.66|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-16-"ABD"-noun-0]|TX|3685/3|
00000000|MMI|2.66|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-16-"ABD"-noun-1]|TX|3685/3|
00000000|MMI|2.66|Active|C0205177|[ftcn]|["Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|Activities|C0441655|[acty]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-10-"ACTIVITY"-noun-1]|TX|2157/8|
00000000|MMI|2.66|Additional comments|C1830770|[fndg]|["Additional comments"-tx-41-"ADDITIONAL COMMENTS"-noun-0]|TX|5284/19|
00000000|MMI|2.66|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-16-"CHEST"-noun-0]|TX|3618/5|
00000000|MMI|2.66|Aspects of signs|C0220912|[ftcn]|["signs"-tx-20-"signs"-noun-0]|TX|4209/5|
00000000|MMI|2.66|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|245/9|
00000000|MMI|2.66|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|245/9|
00000000|MMI|2.66|CDISC SDTM Evaluator Terminology|C2698624|[inpr]|["EVAL"-tx-27-"eval"-noun-0]|TX|4704/4|
00000000|MMI|2.66|Entire neck|C1281592|[bpoc]|["Neck"-tx-16-"NECK"-noun-0]|TX|3605/4|
00000000|MMI|2.66|Evaluator - personnel|C1707957|[prog]|["EVAL"-tx-27-"eval"-noun-0]|TX|4704/4|
00000000|MMI|2.66|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|HP gene|C1415692|[gngm]|["Bp"-tx-16-"BP"-noun-0]|TX|3567/2|
00000000|MMI|2.66|HP wt Allele|C1708288|[gngm]|["BP"-tx-16-"BP"-noun-0]|TX|3567/2|
00000000|MMI|2.66|Manufactured sign|C0220913|[mnob]|["signs"-tx-20-"signs"-noun-0]|TX|4209/5|
00000000|MMI|2.66|NT5E wt Allele|C3889152|[gngm]|["NT"-tx-16-"NT"-noun-0]|TX|3697/2|
00000000|MMI|2.66|No treatment required for|C0332126|[qlco]|["NT"-tx-16-"NT"-noun-0]|TX|3697/2|
00000000|MMI|2.66|Percent Activity|C0439167|[qnco]|["% Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2157/8|
00000000|MMI|2.66|Physical findings|C0311392|[fndg]|["SIGNS"-tx-20-"signs"-noun-0]|TX|4209/5|
00000000|MMI|2.66|S1|C3715215|[fndg]|["S1"-tx-16-"S1"-noun-1]|TX|3649/2|
00000000|MMI|2.66|SSS|C0723181|[phsu]|["SSS"-tx-36-"SSS"-noun-0]|TX|5089/3|
00000000|MMI|2.66|Surg|C3541227|[tmco]|["Surg"-tx-41-"surg"-noun-0]|TX|5739/4|
00000000|MMI|2.66|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-16-"S1"-noun-1]|TX|3649/2|
00000000|MMI|2.66|Tyrosine Nitration|C4050156|[moft]|["NT"-tx-16-"NT"-noun-0]|TX|3697/2|
00000000|MMI|2.66|care activity|C1947933|[acty]|["Care"-tx-13-"care"-noun-0]|TX|3464/4|
00000000|MMI|2.66|dendritic spine neck|C3159206|[celc]|["neck"-tx-16-"NECK"-noun-0]|TX|3605/4|
00000000|MMI|2.66|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-11-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2491/19|
00000000|MMI|2.63|Dose number|C1115464|[qnco]|["Dose number"-tx-10-"Number Doses"-noun-0]|TX|2091/6,2101/5|
00000000|MMI|2.63|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-10-"Number Doses"-noun-0]|TX|2091/6,2101/5|
00000000|MMI|2.63|Entered|C1521975|[qlco]|["Entered"-tx-41-"ENTERED"-verb-0]|TX|5848/7|
00000000|MMI|2.62|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-16-"CV"-noun-0]|TX|3641/2|
00000000|MMI|2.62|Cheque|C1555524|[mnob]|["Cheque"-tx-37-"check"-noun-0]|TX|5140/5|
00000000|MMI|2.62|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-11-"diabetes"-noun-0]|TX|2684/8|
00000000|MMI|2.62|Disposition|C0743223|[idcn]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|315/11|
00000000|MMI|2.62|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|315/11|
00000000|MMI|2.62|GEN1 gene|C2239486|[gngm]|["Gen"-tx-16-"GEN"-noun-0]|TX|3596/3|
00000000|MMI|2.62|Negative|C0205160|[qlco]|["Negative"-tx-20-"negative"-noun-0]|TX|4190/8|
00000000|MMI|2.62|Negative - answer|C3853545|[qlco]|["Negative"-tx-20-"negative"-noun-0]|TX|4190/8|
00000000|MMI|2.62|Negative Charge|C2825491|[qlco]|["Negative"-tx-20-"negative"-noun-0]|TX|4190/8|
00000000|MMI|2.62|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-20-"negative"-noun-0]|TX|4190/8|
00000000|MMI|2.62|Negative Number|C2825415|[cnce]|["Negative"-tx-20-"negative"-noun-0]|TX|4190/8|
00000000|MMI|2.61|rash both legs|C0857236|[dsyn]|["rash legs"-tx-28-"rash legs"-noun-0]|TX|4732/4,4744/4|
00000000|MMI|2.61|Planned|C1301732|[ftcn]|["Plan"-tx-41-"PLAN"-noun-0]|TX|5702/4|
00000000|MMI|2.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-41-"PLAN"-noun-0]|TX|5702/4|
00000000|MMI|2.60|Secondary to|C0175668|[tmco]|["Secondary to"-tx-40-"secondary to"-adj-0]|TX|5235/12|
00000000|MMI|2.60|Every evening|C0585330|[tmco]|["QPM"-tx-5-"QPM"-noun-0]|TX|785/3|
00000000|MMI|2.60|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-5-"QPM"-noun-0]|TX|785/3|
00000000|MMI|2.60|day|C0439228|[tmco]|["DAYS"-tx-14-"days"-noun-0]|TX|3509/4|
00000000|MMI|2.59|Body tissue injury|C2136639|[fndg]|["tissue Wound"-tx-26-"wound tissue"-noun-0]|TX|4557/5,4573/6|
00000000|MMI|2.59|bactrim allergy|C0694572|[dsyn]|["bactrim allergy"-tx-25-"bactrim allergy"-noun-0]|TX|4500/7,4516/7|
00000000|MMI|2.59|Follow-Up Care|C3899107|[hlca]|["Follow-Up Care"-tx-32-"follow up care"-noun-0]|TX|4987/9,5014/4|
00000000|MMI|2.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|113/7|
00000000|MMI|2.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|113/7|
00000000|MMI|2.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|113/7|
00000000|MMI|2.59|Chronic atrial fibrillation|C0694539|[dsyn]|["Chronic AF"-tx-11-"chronic AF"-noun-0]|TX|3207/10|
00000000|MMI|2.59|End|C0444930|[spco]|["End"-tx-42-"END"-noun-0]|TX|5919/3|
00000000|MMI|2.59|Pharmaceutical Preparations|C0013227|[phsu]|["Medicine"-tx-17-"medicine"-noun-0]|TX|3874/8|D26
00000000|MMI|2.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-11-"Responsible"-adj-0]|TX|2512/11|
00000000|MMI|2.59|Started|C1272689|[qlco]|["Started"-tx-21-"Started"-verb-0]|TX|4231/7|
00000000|MMI|2.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-42-"END"-noun-0]|TX|5919/3|
00000000|MMI|2.59|allergic|C0700624|[ftcn]|["Allergic"-tx-22-"Allergic"-adj-0]|TX|4272/8|
00000000|MMI|2.59|ppm|C0439187|[qnco]|["PPM"-tx-36-"PPM"-noun-0]|TX|5103/3|
00000000|MMI|2.57|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|
00000000|MMI|2.57|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|
00000000|MMI|2.57|Antibiotic throat preparations|C3540706|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C3540707|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Antibiotics for systemic use|C3540704|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Antibiotics, Gynecological|C3540708|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Antibiotics, ophthalmologic|C3540710|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Antifungal Antibiotics, Topical|C3540705|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|167/10|
00000000|MMI|2.57|Improvement|C2986411|[cnce]|["Improvement"-tx-31-"improvement"-noun-0]|TX|4938/11|
00000000|MMI|2.57|Negation|C1518422|[ftcn]|["Not"-tx-11-"NOT"-adv-0]|TX|3025/3|
00000000|MMI|2.57|Numerous|C0439064|[qnco]|["Several"-tx-17-"several"-adj-0]|TX|4039/7|
00000000|MMI|2.57|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|2386/7|
00000000|MMI|2.57|Several|C0443302|[qnco]|["Several"-tx-17-"several"-adj-0]|TX|4039/7|
00000000|MMI|2.57|Switch Device Component|C1707719|[mnob]|["Switch"-tx-25-"switch"-noun-0]|TX|4443/6|
00000000|MMI|2.57|antibiotics, intestinal|C3540709|[antb]|["Antibiotics"-tx-41-"antibiotics"-noun-0]|TX|5645/11|
00000000|MMI|2.57|seen|C0205397|[qlco]|["Seen"-tx-27-"seen"-verb-0]|TX|4589/4|
00000000|MMI|2.57|Amputated structure (morphologic abnormality)|C0332840|[acab]|["Amputation"-tx-12-"amputation"-noun-0]|TX|3375/10|
00000000|MMI|2.57|Amputation Specimen Code|C1546539|[inpr]|["Amputation"-tx-12-"amputation"-noun-0]|TX|3375/10|
00000000|MMI|2.57|Concept History|C1705255|[cnce]|["History"-tx-11-"history"-noun-0]|TX|3261/7|
00000000|MMI|2.57|History of present illness|C0262512|[orga]|["History, NOS"-tx-11-"history"-noun-0]|TX|3261/7|
00000000|MMI|2.57|History of previous events|C2004062|[fndg]|["History"-tx-11-"history"-noun-0]|TX|3261/7|
00000000|MMI|2.57|Medical History|C0262926|[fndg]|["History"-tx-11-"history"-noun-0]|TX|3261/7|
00000000|MMI|2.56|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|216/4|
00000000|MMI|2.56|/hour|C0564385|[qnco]|["/hour"-tx-5-"Hour"-noun-0]|TX|811/4|
00000000|MMI|2.56|Evidence|C3887511|[idcn]|["Evidence"-tx-17-"evidence"-noun-0]|TX|3933/8|
00000000|MMI|2.56|Hour|C0439227|[tmco]|["HOUR"-tx-5-"Hour"-noun-0]|TX|811/4|
00000000|MMI|2.55|Agent|C0450442|[chvf]|["Agent"-tx-17-"agents"-noun-0]|TX|4047/6|
00000000|MMI|2.55|Pharmacologic Substance|C1254351|[phsu]|["Agent"-tx-17-"agents"-noun-0]|TX|4047/6|
00000000|MMI|2.55|Protocol Agent|C1521826|[inpr]|["Agent"-tx-17-"agents"-noun-0]|TX|4047/6|
00000000|MMI|2.55|1-2|C3843716|[fndg]|["1-2"-tx-41-"1-2"-integer-0]|TX|5339/3|
00000000|MMI|2.55|1/2|C0580272|[inpr]|["1/2"-tx-41-"1-2"-integer-0]|TX|5339/3|
00000000|MMI|2.55|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|203/3|
00000000|MMI|2.55|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-41-"1-2"-integer-0]|TX|5339/3|
00000000|MMI|2.55|tramadol hydrochloride|C2350089|[orch,phsu]|["tramadol hcl"-tx-10-"TRAMADOL HCL"-noun-0]|TX|2041/12|
00000000|MMI|2.53|Tetrahedral Molecular Geometry|C3641140|[spco]|["T-4"-tx-16-"T 4"-adj-0]|TX|3554/1,3559/1|
00000000|MMI|2.53|20%|C3842589|[fndg]|["20%"-tx-16-"20"-integer-0]|TX|3581/2|
00000000|MMI|2.53|Alert|C3665546|[ftcn]|["Alert"-tx-9-"Alert"-adj-0]|TX|1948/5|
00000000|MMI|2.53|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-9-"Alert"-adj-0]|TX|1948/5|
00000000|MMI|2.53|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-34-"ADA"-noun-0]|TX|5059/3|
00000000|MMI|2.53|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AF"-tx-36-"AF"-noun-0]|TX|5086/2|
00000000|MMI|2.53|Bowel sounds|C0232693|[fndg]|["Bowel sounds"-tx-16-"bowel sounds"-noun-1]|TX|3707/12|
00000000|MMI|2.53|Causing|C0678227|[ftcn]|["Causing"-tx-11-"Causing"-adj-0]|TX|2540/7|
00000000|MMI|2.53|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-9-"Alert"-adj-0]|TX|1948/5|
00000000|MMI|2.53|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Early|C1279919|[tmco]|["Early"-tx-20-"early"-adj-0]|TX|4203/5|
00000000|MMI|2.53|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Genus Ada|C1060325|[plnt]|["Ada"-tx-34-"ADA"-noun-0]|TX|5059/3|
00000000|MMI|2.53|Jugular venous engorgement|C0425687|[fndg]|["JVD"-tx-16-"JVD"-noun-1]|TX|3614/3|
00000000|MMI|2.53|Laboratory Procedures|C0022885|[lbpr]|["Tests"-tx-17-"TESTS"-noun-0]|TX|3887/5|
00000000|MMI|2.53|Local|C0205276|[spco]|["LOCAL"-tx-13-"local"-adj-0]|TX|3458/5|
00000000|MMI|2.53|PSMD4 wt Allele|C4049859|[gngm]|["AF"-tx-36-"AF"-noun-0]|TX|5086/2|
00000000|MMI|2.53|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-16-"soft"-adj-1]|TX|3690/4|
00000000|MMI|2.53|Soft|C0205358|[qlco]|["Soft"-tx-16-"soft"-adj-0]|TX|3690/4|
00000000|MMI|2.53|Tests (qualifier value)|C0392366|[inpr]|["Tests"-tx-17-"TESTS"-noun-0]|TX|3887/5|
00000000|MMI|2.53|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|241/3|
00000000|MMI|2.53|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|241/3|
00000000|MMI|2.53|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-41-"dictated"-adj-0]|TX|5831/8|
00000000|MMI|2.53|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-41-"dictated"-adj-0]|TX|5831/8|
00000000|MMI|2.53|mg/mg|C1319635|[qnco]|["mg/mg"-tx-4-"MG MG"-noun-0]|TX|392/2,428/2|
00000000|MMI|2.51|2/5|C0450346|[qnco]|["2 5"-tx-5-"2.5"-real_number-0]|TX|775/3|
00000000|MMI|2.51|Vitamin K Drug Class|C3714648|[phsu,vita]|["VITAMIN K"-tx-5-"Vitamin-K"-noun-0]|TX|879/9|
00000000|MMI|2.51|Vitamin K [EPC]|C2936884|[phsu]|["Vitamin K"-tx-5-"Vitamin-K"-noun-0]|TX|879/9|
00000000|MMI|2.51|Vitamin K containing hemostatics|C3541380|[orch,phsu,vita]|["Vitamin K"-tx-5-"Vitamin-K"-noun-0]|TX|879/9|
00000000|MMI|2.51|Restricted|C0443288|[ftcn]|["Restriction"-tx-10-"Restrictions"-noun-0]|TX|2144/12|
00000000|MMI|2.51|100%|C3817553|[qnco]|["100%"-tx-16-"100"-percentage-0]|TX|3589/3|
00000000|MMI|2.51|70%|C3842584|[fndg]|["70%"-tx-16-"70"-fraction-0]|TX|3574/2|
00000000|MMI|2.51|Administration procedure|C1533734|[topp]|["Treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|
00000000|MMI|2.51|Axial R|C3538806|[spco]|["Ra"-tx-16-"RA"-noun-0]|TX|3593/2|
00000000|MMI|2.51|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|
00000000|MMI|2.51|Cancer/Testis Antigen|C3813556|[aapp]|["CTA"-tx-16-"CTA"-noun-0]|TX|3625/3|
00000000|MMI|2.51|Fifth|C0205439|[qnco]|["Fifth"-tx-16-"fifth"-noun-0]|TX|3818/5|
00000000|MMI|2.51|Glyburide 2.5 MG|C0986276|[clnd]|["Glyburide 2.5 MG"-tx-4-"GLYBURIDE 2.5 MG"-noun-0]|TX|456/16|
00000000|MMI|2.51|Home environment|C0442519|[cnce]|["HOME"-tx-4-"Home"-noun-0]|TX|328/4|
00000000|MMI|2.51|ITSN2 gene|C1416521|[gngm]|["SWAP"-tx-24-"swap"-noun-0]|TX|4341/4|
00000000|MMI|2.51|Injury wounds|C0043250|[inpo]|["WOUND"-tx-24-"Wound"-noun-0]|TX|4335/5|
00000000|MMI|2.51|Last|C1517741|[qlco]|["Last"-tx-37-"Last"-adj-0]|TX|5131/4|
00000000|MMI|2.51|PCYT1A wt Allele|C3540513|[gngm]|["CTA"-tx-16-"CTA"-noun-0]|TX|3625/3|
00000000|MMI|2.51|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-10-"regular exercise"-noun-0]|TX|2174/16|
00000000|MMI|2.51|Right arm|C4048756|[bpoc]|["RA"-tx-16-"RA"-noun-0]|TX|3593/2|
00000000|MMI|2.51|SFSWAP gene|C1419999|[gngm]|["SWAP"-tx-24-"swap"-noun-0]|TX|4341/4|
00000000|MMI|2.51|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|E02
00000000|MMI|2.51|Traumatic injury|C3263723|[inpo]|["Wound"-tx-24-"Wound"-noun-0]|TX|4335/5|
00000000|MMI|2.51|Treating|C1522326|[ftcn]|["Treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|
00000000|MMI|2.51|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-11-"Treatment"-noun-0]|TX|2669/9|
00000000|MMI|2.51|linezolid 600 MG|C1127473|[clnd]|["linezolid 600 MG"-tx-8-"LINEZOLID 600 MG"-noun-0]|TX|1801/16|
00000000|MMI|2.51|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-11-"Treatment"-noun-0]|TX|2669/9|
00000000|MMI|2.50|Past|C1444637|[tmco]|["Past"-tx-17-"past"-noun-0]|TX|4061/4|
00000000|MMI|2.50|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-41-"Stable"-adj-0]|TX|5689/6|
00000000|MMI|2.50|Present|C0150312|[qnco]|["Present"-tx-16-"present"-adj-0]|TX|3720/7|
00000000|MMI|2.50|Presentation|C0449450|[idcn]|["Present"-tx-16-"present"-adj-0]|TX|3720/7|
00000000|MMI|2.50|Primary|C0205225|[qlco]|["Principal"-tx-11-"PRINCIPAL"-adj-0]|TX|2481/9|
00000000|MMI|2.50|Red color|C1260956|[qlco]|["redness"-tx-11-"redness"-noun-0]|TX|3126/7|
00000000|MMI|2.50|Redness|C0332575|[fndg]|["Redness"-tx-11-"redness"-noun-0]|TX|3126/7|
00000000|MMI|2.50|Stable status|C0205360|[qlco]|["STABLE"-tx-41-"Stable"-adj-0]|TX|5689/6|
00000000|MMI|2.50|Teaching principal|C0401925|[prog]|["Principal"-tx-11-"PRINCIPAL"-adj-0]|TX|2481/9|
00000000|MMI|2.50|Ulceration Adverse Event|C1963256|[fndg]|["Ulceration"-tx-11-"ulceration"-noun-0]|TX|3115/10|
00000000|MMI|2.50|diabetic|C0241863|[fndg]|["DIABETIC"-tx-11-"Diabetic"-adj-0]|TX|2587/8|
00000000|MMI|2.50|Abnormally high|C1299351|[qlco]|["High"-tx-5-"high"-adj-0]|TX|874/4|
00000000|MMI|2.50|Contain (action)|C2700400|[acty]|["Containing"-tx-5-"containing"-adj-0]|TX|889/10|
00000000|MMI|2.50|Containing (qualifier)|C0332256|[ftcn]|["Containing"-tx-5-"containing"-adj-0]|TX|889/10|
00000000|MMI|2.50|High Mitosis-Karyorrhexis Index|C3889660|[qnco]|["High"-tx-5-"high"-adj-0]|TX|874/4|
00000000|MMI|2.50|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-5-"MG"-noun-0]|TX|779/2|
00000000|MMI|2.50|Milligram percent|C1960952|[qnco]|["mg %"-tx-5-"MG"-noun-0]|TX|779/2|
00000000|MMI|2.50|Value Above Reference Range|C2700149|[inpr]|["HIGH"-tx-5-"high"-adj-0]|TX|874/4|
00000000|MMI|2.50|high - ActExposureLevelCode|C3887512|[idcn]|["high"-tx-5-"high"-adj-0]|TX|874/4|
00000000|MMI|2.50|mg/dL|C0439269|[qnco]|["mg%"-tx-5-"MG"-noun-0]|TX|779/2|
00000000|MMI|2.50|Day 7|C3842672|[fndg]|["Day 7"-tx-41-"7 days"-noun-0]|TX|5661/6|
00000000|MMI|2.49|Concept model range (foundation metadata concept)|C3542016|[inpr]|["Range"-tx-1-"Range"-noun-0]|TX|107/5|
00000000|MMI|2.49|Left upper arm structure|C0230347|[bpoc]|["LA"-tx-1-"La"-noun-0]|TX|95/2|
00000000|MMI|2.49|Lupus Anticoagulant Antibody|C2346906|[aapp,imft]|["LA"-tx-1-"La"-noun-0]|TX|95/2|
00000000|MMI|2.49|Range|C1514721|[qnco]|["Range"-tx-1-"Range"-noun-0]|TX|107/5|
00000000|MMI|2.49|Sample Range|C2348147|[qnco]|["Range"-tx-1-"Range"-noun-0]|TX|107/5|
00000000|MMI|2.49|Bactrim DS|C1154231|[orch,phsu]|["Bactrim DS"-tx-5-"BACTRIM DS"-noun-0]|TX|990/10|
00000000|MMI|2.49|Infectious Disease Pathway|C3714515|[ftcn]|["Infectious Disease"-tx-8-"infectious disease"-noun-0]|TX|1883/18|
00000000|MMI|2.49|Room of building - Study|C0557651|[mnob]|["Study"-tx-11-"Study"-noun-0]|TX|2530/5|
00000000|MMI|2.49|Study|C2603343|[resa]|["Study"-tx-11-"Study"-noun-0]|TX|2530/5|
00000000|MMI|2.49|/40|C0439509|[tmco]|["/40"-tx-4-"40"-integer-0]|TX|425/2|
00000000|MMI|2.49|40%|C3842587|[qnco]|["40%"-tx-4-"40"-integer-0]|TX|425/2|
00000000|MMI|2.49|Every six hours|C0585325|[tmco]|["Q6H"-tx-4-"Q6H"-noun-0]|TX|398/3|
00000000|MMI|2.48|Hospital course|C0489547|[fndg]|["Hospital course"-tx-11-"HOSPITAL COURSE"-noun-1]|TX|3069/15|
00000000|MMI|2.48|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-11-"HOSPITAL COURSE"-noun-0]|TX|3069/15|
00000000|MMI|2.48|HPS4 gene|C1423767|[gngm]|["LE"-tx-11-"LE"-noun-0]|TX|3282/2|
00000000|MMI|2.48|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-11-"LE"-noun-0]|TX|3282/2|
00000000|MMI|2.48|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-11-"LE"-noun-0]|TX|3282/2|
00000000|MMI|2.48|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-40-"DM"-noun-0]|TX|5248/2|
00000000|MMI|2.48|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-40-"likely"-adv-0]|TX|5228/6|
00000000|MMI|2.48|Probably|C0750492|[idcn]|["Likely"-tx-40-"likely"-adv-0]|TX|5228/6|
00000000|MMI|2.48|Recurrent|C2945760|[tmco]|["RECURRENT"-tx-11-"recurrent"-adj-0]|TX|3272/9|
00000000|MMI|2.48|consider|C0750591|[idcn]|["considering"-tx-12-"considering"-adj-0]|TX|3363/11|
00000000|MMI|2.47|6/4.5|C1631070|[fndg]|["20/15"-tx-6-"20 15"-fraction-0]|TX|1282/2,1309/2|
00000000|MMI|2.47|Base|C0178499|[chvf]|["Base"-tx-16-"base"-noun-0]|TX|3668/4|
00000000|MMI|2.47|Dental Base|C1880279|[bodm]|["Base"-tx-16-"base"-noun-0]|TX|3668/4|
00000000|MMI|2.47|PACERR gene|C3890506|[gngm]|["PACER"-tx-11-"pacer"-noun-0]|TX|3231/5|
00000000|MMI|2.47|PSMD2 gene|C1419032|[gngm]|["S2"-tx-16-"S2"-noun-0]|TX|3654/2|
00000000|MMI|2.47|RPS2 gene|C1419718|[gngm]|["S2"-tx-16-"S2"-noun-0]|TX|3654/2|
00000000|MMI|2.47|Receive|C1514756|[qlco]|["RECEIVED"-tx-8-"received"-adj-0]|TX|1874/8|
00000000|MMI|2.47|S2|C3812876|[fndg]|["S2"-tx-16-"S2"-noun-1]|TX|3654/2|
00000000|MMI|2.47|S2 innervation|C1179705|[blor]|["S2"-tx-16-"S2"-noun-0]|TX|3654/2|
00000000|MMI|2.47|Structure of base of heart|C0225810|[blor]|["Base"-tx-16-"base"-noun-0]|TX|3668/4|
00000000|MMI|2.47|Testicular Cancer Serum Markers Test Result S2|C3812875|[lbtr]|["S2"-tx-16-"S2"-noun-1]|TX|3654/2|
00000000|MMI|2.47|% release (qualifier value)|C0439180|[qnco]|["% release"-tx-5-"RELEASE"-adj-0]|TX|614/7|
00000000|MMI|2.47|Discharge (release)|C0680255|[hlca]|["release"-tx-5-"RELEASE"-adj-0]|TX|614/7|
00000000|MMI|2.47|Hindfoot (body structure)|C0230459|[blor]|["Hindfoot"-tx-16-"hindfoot"-noun-0]|TX|3776/8|
00000000|MMI|2.47|Hindfoot of quadruped|C3853547|[bpoc]|["Hindfoot"-tx-16-"hindfoot"-noun-0]|TX|3776/8|
00000000|MMI|2.47|Release (procedure)|C1963578|[topp]|["Release"-tx-5-"RELEASE"-adj-0]|TX|614/7|
00000000|MMI|2.47|Release - action (qualifier value)|C1283071|[ftcn]|["Release"-tx-5-"RELEASE"-adj-0]|TX|614/7|
00000000|MMI|2.47|Released (action)|C0391871|[ftcn]|["Release"-tx-5-"RELEASE"-adj-0]|TX|614/7|
00000000|MMI|2.47|Slow|C0439834|[qlco]|["Slow"-tx-5-"SLOW"-adj-0]|TX|609/4|
00000000|MMI|2.47|Varus|C0443345|[spco]|["Varus"-tx-16-"varus"-adj-0]|TX|3785/5|
00000000|MMI|2.47|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-11-"BRIEF"-adj-0]|TX|3053/5|
00000000|MMI|2.47|Brief|C1879313|[tmco]|["Brief"-tx-11-"BRIEF"-adj-0]|TX|3053/5|
00000000|MMI|2.47|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-11-"cxr"-noun-0]|TX|3049/3|
00000000|MMI|2.47|Shortened|C1282927|[qlco]|["brief"-tx-11-"BRIEF"-adj-0]|TX|3053/5|
00000000|MMI|2.47|MRC1 gene|C1417249|[gngm]|["MR"-tx-17-"MR"-noun-0]|TX|3958/2|
00000000|MMI|2.47|Minor Response|C4050513|[fndg]|["MR"-tx-17-"MR"-noun-1]|TX|3958/2|
00000000|MMI|2.47|Mr. - Title|C2347167|[cnce]|["Mr."-tx-17-"MR"-noun-0]|TX|3958/2|
00000000|MMI|2.47|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-6-"QHS"-noun-0]|TX|1291/3|
00000000|MMI|2.46|Foot reconstruction|C1293304|[topp]|["Foot reconstruction"-tx